Hypoxia and Hypercoagulability in COVID-19: Chicken or the Egg?
作者信息
Douin David J, Fernandez-Bustamante Ana
机构信息
Department of Anesthesiology, University of Colorado School of Medicine, Aurora, Colorado.
出版信息
Anesthesiology. 2022 Jul 1;137(1):13-14. doi: 10.1097/ALN.0000000000004241.
Abstract
摘要
相似文献
1
Hypoxia and Hypercoagulability in COVID-19: Chicken or the Egg?新冠病毒肺炎中的缺氧与高凝状态：先有鸡还是先有蛋？
Anesthesiology. 2022 Jul 1;137(1):13-14. doi: 10.1097/ALN.0000000000004241.
2
COVID‑19 and ischemic stroke: Mechanisms of hypercoagulability (Review).COVID-19 与缺血性脑卒中：高凝状态的机制（综述）。
Int J Mol Med. 2021 Mar;47(3). doi: 10.3892/ijmm.2021.4854. Epub 2021 Jan 15.
3
Hypercoagulability following COVID-19 infection: at what stage is it safe to do a free flap?新型冠状病毒肺炎感染后的高凝状态：进行游离皮瓣手术在哪个阶段是安全的？
Br J Oral Maxillofac Surg. 2020 Dec;58(10):e232-e233. doi: 10.1016/j.bjoms.2020.08.092. Epub 2020 Aug 20.
4
Blood Hyperviscosity: A Novel Link Between Hyperinflammation and Hypercoagulability in COVID-19.血液高黏滞性：新冠病毒肺炎中过度炎症与高凝状态之间的新联系
J Am Coll Cardiol. 2022 Jul 26;80(4):329-331. doi: 10.1016/j.jacc.2022.04.061.
5
COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and Pregnancy.2019冠状病毒病与高凝状态：对口服避孕药、雌激素治疗及妊娠管理的潜在影响
Endocrinology. 2020 Dec 1;161(12). doi: 10.1210/endocr/bqaa121.
6
Fibrinolysis Shutdown in COVID-19: Clinical Manifestations, Molecular Mechanisms, and Therapeutic Implications.COVID-19 中的纤维蛋白溶解关闭：临床特征、分子机制和治疗意义。
J Am Coll Surg. 2021 Jun;232(6):995-1003. doi: 10.1016/j.jamcollsurg.2021.02.019. Epub 2021 Mar 22.
7
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.全球止血检测表明非缺氧性轻症 COVID-19 患者不存在高凝状态参数：一项前瞻性匹配研究。
J Thromb Thrombolysis. 2022 Apr;53(3):646-662. doi: 10.1007/s11239-021-02575-4. Epub 2021 Sep 28.
8
Physiologic and biochemical rationale for treating COVID-19 patients with hyperbaric oxygen.高压氧治疗 COVID-19 患者的生理和生化原理。
Undersea Hyperb Med. 2021 First Quarter;48(1):1-12. doi: 10.22462/01.03.2021.1.
9
COVID-19 coagulopathy - what should we treat?COVID-19 相关凝血功能障碍——我们应该治疗什么？
Exp Physiol. 2022 Jul;107(7):749-758. doi: 10.1113/EP089404. Epub 2022 Jun 22.
10
Global haemostatic tests demonstrate the absence of parameters of hypercoagulability in non-hypoxic mild COVID-19 patients: a prospective matched study.全球止血测试表明，非低氧轻症新冠患者不存在高凝状态参数：一项前瞻性配对研究。
J Thromb Thrombolysis. 2022 Apr;53(3):731-733. doi: 10.1007/s11239-021-02612-2. Epub 2021 Nov 20.
本文引用的文献
1
Suppression of Fibrinolysis and Hypercoagulability, Severity of Hypoxemia, and Mortality in COVID-19 Patients: A Retrospective Cohort Study.新冠肺炎患者纤溶抑制和高凝状态、低氧血症严重程度与死亡率的关系：一项回顾性队列研究。
Anesthesiology. 2022 Jul 1;137(1):67-78. doi: 10.1097/ALN.0000000000004239.
2
The Central Role of PAI-1 in COVID-19: Thrombosis and beyond.纤溶酶原激活物抑制剂-1（PAI-1）在新冠病毒疾病（COVID-19）中的核心作用：血栓形成及其他影响
Am J Respir Cell Mol Biol. 2021 Sep;65(3):238-240. doi: 10.1165/rcmb.2021-0208ED.
3
ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.ZMPSTE24 调控 SARS-CoV-2 刺突蛋白增强内皮细胞 PAI-1 的表达。
Am J Respir Cell Mol Biol. 2021 Sep;65(3):300-308. doi: 10.1165/rcmb.2020-0544OC.
4
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.COVID-19 和凝血：SARS-CoV-2 感染的出血和血栓形成表现。
Blood. 2020 Jul 23;136(4):489-500. doi: 10.1182/blood.2020006520.
5
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.新型冠状病毒肺炎的肺血管内皮细胞炎症、血栓形成和血管生成。
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
6
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
7
Hypoxia and HIF activation as a possible link between sepsis and thrombosis.缺氧与低氧诱导因子激活：脓毒症与血栓形成之间的潜在联系
Thromb J. 2019 Aug 14;17:16. doi: 10.1186/s12959-019-0205-9. eCollection 2019.
8
Hypoxia and Ischemia Promote a Maladaptive Platelet Phenotype.缺氧和缺血促进适应性血小板表型。
Arterioscler Thromb Vasc Biol. 2018 Jul;38(7):1594-1606. doi: 10.1161/ATVBAHA.118.311186. Epub 2018 May 3.
9
Impact of thrombosis on pulmonary endothelial injury and repair following sepsis.血栓形成对败血症后肺内皮损伤及修复的影响。
Am J Physiol Lung Cell Mol Physiol. 2017 Apr 1;312(4):L441-L451. doi: 10.1152/ajplung.00441.2016. Epub 2017 Jan 27.
10
Hypoxia-reoxygenation-induced endothelial barrier failure: role of RhoA, Rac1 and myosin light chain kinase.缺氧/复氧诱导的内皮屏障功能障碍：RhoA、Rac1 和肌球蛋白轻链激酶的作用。
J Physiol. 2013 Jan 15;591(2):461-73. doi: 10.1113/jphysiol.2012.237834. Epub 2012 Oct 22.
Zotero 插件